Biotechnology
New Molecular Tool for Mitochondrial Genome Editing
by Yazmin I. Rovira Gonzalez, Ph.D., JHU Alumna CRISPR-Cas9 technology is a powerful tool for editing genomes, as it allows researchers to alter DNA sequences
HBN CASSS Mentorship Program and Industry Sponsorship Program
W. Taylor Cottle, PhD Candidate, HBN President The Hopkins Biotech Network continues to work towards building its network with industry and local leaders in the
Hopkins Biotech Podcast
Roshan Chikarmane, Co-Director of Alumni Relations, Ph.D. Candidate at Johns Hopkins School of Medicine Curious about career opportunities for life science students in pharmaceuticals, biotechnology,
“How children may be affected by misinformation about vaccines”
John Jones, M.S. Biotechnology Johns Hopkins University Alumnus In 1796, Edward Jenner devised a method to protect individuals from smallpox by using blisters of someone
Innovation in American Healthcare in the Search for a Vaccine
Tawny Hammett, M.S. Individualized Genomics & Health Johns Hopkins University Alumna The COVID-19 pandemic is slowly starting to makes its way to a period of
COVID-19 and mRNA Vaccines: Fundamentals and Therapeutic Potential
Yazmin I. Rovira Gonzalez, PhD, Johns Hopkins UniversityAlumna On May 18th 2020, Moderna, Inc. – a clinical-stage biotechnology company focused on mRNA technologies, including messenger
Universal Vaccine Perspective- What is the premise, where might it be especially useful (flu + corona seasonality)
Lawrence Jones, PhD- Johns Hopkins University Alumnus Universal vaccines may be a game changer for future infections. Researchers say a universal flu vaccine could be
All Hands on Deck: COVID-19 mobilizing the Public Benefit Pharmaceutical Company collaboration model
Veta Obazenu, M.S. The World Health Organization (WHO) estimates that more than 1 billion people – one sixth of the world’s population — suffer from
COVID-19: Forward Strategies
by Tawney Hammet, M.S. Individualized Genomics & Health Candidate Johns Hopkins University Humanity is currently facing a new mortal enemy, SARS-CoV-2, or more commonly known
Interested in writing for us?
Categories
OUR SPONSORS
